Genomic correction of familial cardiomyopathy in human engineered cardiac tissues
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
In this study, we used three-dimensional human engineered cardiac tissue technology to directly show that phospholamban (PLN) R14del mutation impairs cardiac contractility and to demonstrate restoration of contractile properties with targeted genetic correction of this inheritable form of dilated cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Prior cardiac tissue engineering studies have shown this in the context of arrhythmogenicity [33], contractility [14,34] and recapitulation of disease phenotypes [12,48].”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to prior cardiac disease modeling approaches focused on genetic mutations, 20,42,43 this study demonstrates the use of biologics for induction of disease without requiring patient-specific human induced pluripotent stem cells.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haghighi, K., Kolokathis, F., Gramolini, A. O., Waggoner, J. R., Pater, L., Lynch, R. A., Fan, G.-C., Tsiapras, D., Parekh, R. R., Dorn, G. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510519103 · Cited by 359 · cited 1×
“contractile dysfunction, episodic ventricular arrhythmias, and heart failure.(1) To understand the molecular mechanism underlying the”
BackgroundSelf-citationKarakikes, I., Stillitano, F., Nonnenmacher, M., Tzimas, C., Sanoudou, D., Termglinchan, V., Kong, C.-W., Rushing, S., Hansen, J., Ceholski, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms7955 · Cited by 196 · cited 5×
“0080), a direct functional manifestation of the abnormal calcium handling observed in cultured R14del-CMs.(4) Interestingly, the developed force, +dF/dt and 2dF/dt values from corrected”
BackgroundMethodSelf-citationAdvancing functional engineered cardiac tissues toward a preclinical model of human myocardium
Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-228007 · Cited by 184 · cited 1×
“moulds, with integrated cantilever end-posts for non-invasive measurement of contractile function.(5)”
BackgroundSelf-citationGenome editing of human pluripotent stem cells to generate human cellular disease models
Musunuru, K. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012054 · Cited by 170
The Regulation of SERCA‐Type Pumps by Phospholamban and Sarcolipin
MacLENNAN, D. H., ASAHI, M., & TUPLING, A. R. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07231.x · Cited by 167 · cited 1×
“Some forms of DCM are hereditary, and one of the genes found to be associated with inherited DCM is the one encoding phospholamban (PLN),(1,2) a protein that regulates the sarcoplasmic reticulum Ca2+ ATPase (SERCA2a).(3) Several PLN mutations, including a deletion of arginine 14 codon (R14del), have been linked to her…”
Backgroundvan Spaendonck-Zwarts, K. Y., van Rijsingen, I. A. W., van den Berg, M. P., Lekanne Deprez, R. H., Post, J. G., van Mil, A. M., Asselbergs, F. W., Christiaans, I., van Langen, I. M., Wilde, A. A. M., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft013 · Cited by 161
Bidirectional Modulation of Cystine/Glutamate Exchanger Activity in Cultured Cortical Astrocytes
Tang, X., & Kalivas, P. W. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.056 · Cited by 58
Cited by
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
“These same cells were used to engineer 3-dimensional human heart tissues, and in this setting, more clear cut cardiomyopathic features were seen including reduced developed force that was improved after genetic correction.(107) In iPSC-derived cardiomyocytes and in hearts from PLN mutation carriers, aggregates of phos…”
Differentiation of cardiomyocytes and generation of human engineered heart tissue
Breckwoldt, K., Letuffe-Brenière, D., Mannhardt, I., Schulze, T., Ulmer, B., Werner, T., Benzin, A., Klampe, B., Reinsch, M. C., Laufer, S., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.033 · Cited by 272
Mosqueira, D., Mannhardt, I., Bhagwan, J. R., Lis-Slimak, K., Katili, P., Scott, E., Hassan, M., Prondzynski, M., Harmer, S. C., Tinker, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy249 · Cited by 238
“was restored in corrected 3D engineered cardiac tissue, although this was the only phenotype assessed.(21) We created a comprehensive hPSC-based model of HCM via”
Li, R. A., Keung, W., Cashman, T. J., Backeris, P. C., Johnson, B. V., Bardot, E. S., Wong, A. O. T., Chan, P. K. W., Chan, C. W. Y., & Costa, K. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.024 · Cited by 175
Self-citationGlobal position paper on cardiovascular regenerative medicine
Fernández-Avilés, F., Sanz-Ruiz, R., Climent, A. M., Badimon, L., Bolli, R., Charron, D., Fuster, V., Janssens, S., Kastrup, J., Kim, H.-S., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx248 · Cited by 159
“by using human cardiomyocytes obtained by directed differentiation of iPSC derived from patients with cardiomyopathy).(137,138)”
Method
Metadata
- Authors
- Stillitano, F., Turnbull, I. C., Karakikes, I., Nonnenmacher, M., Backeris, P., Hulot, J.-S., Kranias, E. G., Hajjar, R. J., & Costa, K. D.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Stanford Cardiovascular Institute (US)
- Assistance Publique – Hôpitaux de Paris (FR)
- University of Cincinnati (US)
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-07-22
- Volume
- 37
- Issue
- 43
- Pages
- 3282-3284
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC6425468
- OpenAlex
- W2484920250
- Cited by
- 77
- References
- 7
- Citations by year
- 2025: 6 · 2024: 7 · 2023: 13 · 2022: 8 · 2021: 8 · 2020: 5 · 2019: 8 · 2018: 12 · 2017: 8 · 2016: 2
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- European Heart Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL026057, R01HL064018)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- familial cardiomyopathy, dilated cardiomyopathy, phospholamban, engineered heart tissue, gene therapy, cardiac contractility
- MeSH terms
- Calcium-Binding Proteins, Humans, Mutation, Cardiomyopathies, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genomic correction of familial cardiomyopathy in human engineered cardiac tissues. https://app.cochat.ai/papers/10.1093/eurheartj/ehw307
- The paper
- Stillitano, F., Turnbull, I. C., Karakikes, I., Nonnenmacher, M., Backeris, P., Hulot, J.-S., Kranias, E. G., Hajjar, R. J., & Costa, K. D. (2016). Genomic correction of familial cardiomyopathy in human engineered cardiac tissues. European Heart Journal. https://doi.org/10.1093/eurheartj/ehw307
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.